Epidemiological profile of resistance to anti-Tuberculosis drugs in the district of La Victoria, Lima
DOI:
https://doi.org/10.18050/RevUcv-Scientia.v9n2a7Keywords:
Tuberculosis, Resistance, Drugs, EpidemiologyAbstract
Peru is a country with a high burden of tuberculosis disease and high prevalence of its resistant forms. The purpose of the study was to determine the epidemiological profile of resistance to anti-tuberculosis drugs in patients with PPB-TB who are treated at the health facilities of the district of La Victoria during the study period. An observational cross-sectional study was performed. Where cases of TBP FP were recruited in the La Victoria district. 120 cases were included in the analysis, of which 86 (71.7%) had no history of treatment and 34 (28.3%) had a history of treatment (NT). 81 were men (67.5%) and 39 women (32.5%). Resistance to one or more drugs was 21% in the NT and 41.2% in the TA. Streptomycin obtained the highest value of monoresistance in both new and previously treated cases. The MDR pattern was present in 35.2% of AT and 4.6% of NT.
The study showed that the district of La Victoria DISA V Lima City has a high initial MDR TB burden, with a high prevalence of secondary resistance.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
